内克塔治疗(NKTR)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

NKTR 内克塔治疗

休市中 01-10 16:00:00 EST

1.03

-0.11

-9.65%

盘后1.07

+0.04+3.88%

19:26 EST

最高1.12	最低1.02	成交量165.14万
今开1.10	昨收1.14	日振幅8.77%
总市值1.90亿	流通市值1.71亿	总股本1.84亿
成交额175.70万	换手率1.00%	流通股本1.66亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"NKTR","market":"US","secType":"STK","nameCN":"内克塔治疗","latestPrice":1.03,"timestamp":1736542800000,"preClose":1.14,"halted":0,"volume":1651397,"hourTrading":{"tag":"盘后","latestPrice":1.07,"preClose":1.03,"latestTime":"19:26 EST","volume":15261,"amount":15781.83,"timestamp":1736555168592},"delay":0,"floatShares":165825396,"shares":184458284,"eps":-0.837394,"marketStatus":"休市中","change":-0.11,"latestTime":"01-10 16:00:00 EST","open":1.1,"high":1.12,"low":1.02,"amount":1756961.2321074,"amplitude":0.087719,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-0.837394,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1736758800000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":1.14,"preHourTrading":{"tag":"盘前","latestPrice":1.11,"preClose":1.14,"latestTime":"09:28 EST","volume":37507,"amount":43811.585386299994,"timestamp":1736519290672},"postHourTrading":{"tag":"盘后","latestPrice":1.07,"preClose":1.03,"latestTime":"19:26 EST","volume":15261,"amount":15781.83,"timestamp":1736555168592},"volumeRatio":0.7694966930744078,"impliedVol":2.4748,"impliedVolPercentile":0.8964},"requestUrl":"/m/hq/s/NKTR/wiki","defaultTab":"wiki","newsList":[{"id":"2502486257","title":"内克塔治疗盘中异动 大幅下挫5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2502486257","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2502486257?lang=zh_cn&edition=full","pubTime":"2025-01-10 22:36","pubTimestamp":1736519814,"startTime":"0","endTime":"0","summary":"北京时间2025年01月10日22时36分，内克塔治疗股票出现波动，股价快速跳水5.26%。截至发稿，该股报1.08美元/股，成交量16.1195万股，换手率0.09%，振幅2.19%。机构评级方面，在所有9家参与评级的机构中，44%的券商给予买入建议，44%的券商给予持有建议，12%的券商给予卖出建议。内克塔治疗股票所在的生物技术行业中，整体跌幅为0.77%。内克塔治疗公司简介：Nektar Therapeutics 是一家制药公司，专注于发现和开发选择性调节免疫系统以治疗自身免疫性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501102236559861e962&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501102236559861e962&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","NKTR"],"gpt_icon":0},{"id":"2501774771","title":"内克塔治疗盘中异动 早盘股价大跌5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2501774771","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2501774771?lang=zh_cn&edition=full","pubTime":"2025-01-08 23:04","pubTimestamp":1736348658,"startTime":"0","endTime":"0","summary":"北京时间2025年01月08日23时04分，内克塔治疗股票出现异动，股价大幅跳水5.04%。截至发稿，该股报1.13美元/股，成交量47.2001万股，换手率0.26%，振幅9.24%。机构评级方面，在所有9家参与评级的机构中，44%的券商给予买入建议，44%的券商给予持有建议，12%的券商给予卖出建议。内克塔治疗股票所在的生物技术行业中，整体跌幅为0.02%。内克塔治疗公司简介：Nektar Therapeutics 是一家制药公司，专注于发现和开发选择性调节免疫系统以治疗自身免疫性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250108230419aba353ac&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250108230419aba353ac&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NKTR","BK4007"],"gpt_icon":0},{"id":"2501871940","title":"美国研究综述-通用电气医疗保健、Summit Materials、Tapestry","url":"https://stock-news.laohu8.com/highlight/detail?id=2501871940","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2501871940?lang=zh_cn&edition=full","pubTime":"2025-01-08 15:37","pubTimestamp":1736321825,"startTime":"0","endTime":"0","summary":"美国研究综述-通用电气医疗保健、Summit Materials、Tapestry路透1月8日 - 华尔街证券分析师周三调整了对几家美国上市公司的评级和目标价，其中包括通用电气医疗保健、Summit Materials 和 Tapestry。要闻 * 通用电气医疗GEHC.O：杰富瑞将其评级从 \"持有 \"上调至 \"买入 * 菲利普莫里斯国际公司PM.N：巴克莱将其目标价从 155 美元下调至 145 美元 * Regeneron Pharmaceuticals Inc REGN.O：Truist Securities 将目标价从 1126 美元下调至 1004 美元 * Summit Materials Inc SUM.N：Stephens将其评级从 \"增持 \"下调至 \"等权重\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250108:nL4S3O40GG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NEE","LU0963586101.USD","LU0070302665.USD","RDN","AFRM","TPR","NARI","SUM","LNN","IE00BVYPNV92.GBP","NEP","MRK","TLN","SG9999001440.SGD","GNW","BIIB","IE00B4R5TH58.HKD","BK4082","PHR","LEVI","RPM","LU1718418525.SGD","LU0545039389.USD","LU2361045086.USD","STC","BK4007","GEHC","FNF","AMGN","MTH","NKTR","GB00B4QBRK32.GBP","LU0882574055.USD","LU0738911758.USD","LU1621767810.EUR","NMIH","PM","IE0009355771.USD","ACT","FAF","GTY","BMY","ABBV","CEG","LU1839511570.USD","MTG","REGN"],"gpt_icon":1},{"id":"2501781996","title":"内克塔治疗盘中异动 快速拉升5.07%报1.23美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2501781996","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2501781996?lang=zh_cn&edition=full","pubTime":"2025-01-07 23:58","pubTimestamp":1736265525,"startTime":"0","endTime":"0","summary":"北京时间2025年01月07日23时58分，内克塔治疗股票出现波动，股价大幅上涨5.07%。截至发稿，该股报1.23美元/股，成交量76.8026万股，换手率0.42%，振幅7.21%。机构评级方面，在所有8家参与评级的机构中，38%的券商给予买入建议，50%的券商给予持有建议，12%的券商给予卖出建议。内克塔治疗股票所在的生物技术行业中，整体涨幅为1.32%。内克塔治疗公司简介：Nektar Therapeutics 是一家制药公司，专注于发现和开发选择性调节免疫系统以治疗自身免疫性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025010723584595fbae54&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025010723584595fbae54&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","NKTR"],"gpt_icon":0},{"id":"2501825394","title":"内克塔治疗盘中异动 早盘股价大涨5.00%报1.16美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2501825394","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2501825394?lang=zh_cn&edition=full","pubTime":"2025-01-06 22:54","pubTimestamp":1736175287,"startTime":"0","endTime":"0","summary":"北京时间2025年01月06日22时54分，内克塔治疗股票出现异动，股价急速拉升5.00%。截至发稿，该股报1.16美元/股，成交量23.1397万股，换手率0.13%，振幅2.73%。机构评级方面，在所有8家参与评级的机构中，38%的券商给予买入建议，50%的券商给予持有建议，12%的券商给予卖出建议。内克塔治疗股票所在的生物技术行业中，整体涨幅为0.23%。内克塔治疗公司简介：Nektar Therapeutics 是一家制药公司，专注于发现和开发选择性调节免疫系统以治疗自身免疫性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025010622544795fa7758&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025010622544795fa7758&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","NKTR"],"gpt_icon":0},{"id":"2500111072","title":"内克塔治疗盘中异动 早盘快速拉升5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2500111072","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2500111072?lang=zh_cn&edition=full","pubTime":"2025-01-03 22:33","pubTimestamp":1735914805,"startTime":"0","endTime":"0","summary":"北京时间2025年01月03日22时33分，内克塔治疗股票出现波动，股价急速拉升5.10%。截至发稿，该股报1.010美元/股，成交量17.1158万股，换手率0.09%，振幅4.16%。机构评级方面，在所有8家参与评级的机构中，38%的券商给予买入建议，50%的券商给予持有建议，12%的券商给予卖出建议。内克塔治疗股票所在的生物技术行业中，整体涨幅为0.28%。内克塔治疗公司简介：Nektar Therapeutics 是一家制药公司，专注于发现和开发选择性调节免疫系统以治疗自身免疫性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250103223325ab9d5ae6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250103223325ab9d5ae6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","NKTR"],"gpt_icon":0},{"id":"2500927744","title":"内克塔治疗盘中异动 早盘急速上涨5.32%报0.980美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2500927744","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2500927744?lang=zh_cn&edition=full","pubTime":"2025-01-02 22:53","pubTimestamp":1735829580,"startTime":"0","endTime":"0","summary":"北京时间2025年01月02日22时53分，内克塔治疗股票出现异动，股价大幅上涨5.32%。截至发稿，该股报0.980美元/股，成交量3.9983万股，换手率0.02%，振幅4.54%。机构评级方面，在所有8家参与评级的机构中，38%的券商给予买入建议，50%的券商给予持有建议，12%的券商给予卖出建议。内克塔治疗股票所在的生物技术行业中，整体涨幅为0.99%。内克塔治疗公司简介：Nektar Therapeutics 是一家制药公司，专注于发现和开发选择性调节免疫系统以治疗自身免疫性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250102225300a2130686&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250102225300a2130686&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NKTR","BK4007"],"gpt_icon":0},{"id":"2494897571","title":"内克塔治疗盘中异动 临近收盘股价大涨5.16%报0.955美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2494897571","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2494897571?lang=zh_cn&edition=full","pubTime":"2024-12-27 04:33","pubTimestamp":1735245192,"startTime":"0","endTime":"0","summary":"北京时间2024年12月27日04时33分，内克塔治疗股票出现波动，股价急速上涨5.16%。截至发稿，该股报0.955美元/股，成交量94.4405万股，换手率0.51%，振幅7.49%。最近的财报数据显示，该股实现营业收入24.12百万美元，净利润-37.06百万美元，每股收益-0.18美元，毛利19.69百万美元，市盈率-1.13倍。内克塔治疗股票所在的生物技术行业中，整体涨幅为0.41%。内克塔治疗公司简介：Nektar Therapeutics 是一家制药公司，专注于发现和开发选择性调节免疫系统以治疗自身免疫性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024122704331295ee2976&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024122704331295ee2976&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NKTR","BK4007"],"gpt_icon":0},{"id":"2493551761","title":"内克塔治疗盘中异动 股价大跌5.19%报0.880美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2493551761","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493551761?lang=zh_cn&edition=full","pubTime":"2024-12-23 23:12","pubTimestamp":1734966728,"startTime":"0","endTime":"0","summary":"北京时间2024年12月23日23时12分，内克塔治疗股票出现波动，股价快速跳水5.19%。截至发稿，该股报0.880美元/股，成交量19.5947万股，换手率0.11%，振幅4.19%。机构评级方面，在所有8家参与评级的机构中，38%的券商给予买入建议，50%的券商给予持有建议，12%的券商给予卖出建议。内克塔治疗股票所在的生物技术行业中，整体涨幅为0.20%。内克塔治疗公司简介：Nektar Therapeutics 是一家制药公司，专注于发现和开发选择性调节免疫系统以治疗自身免疫性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241223231208984d3c3c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241223231208984d3c3c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NKTR","BK4007"],"gpt_icon":0},{"id":"2492109974","title":"内克塔治疗盘中异动 急速上涨5.23%报0.974美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492109974","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492109974?lang=zh_cn&edition=full","pubTime":"2024-12-20 00:50","pubTimestamp":1734627017,"startTime":"0","endTime":"0","summary":"北京时间2024年12月20日00时50分，内克塔治疗股票出现异动，股价急速拉升5.23%。截至发稿，该股报0.974美元/股，成交量59.2135万股，换手率0.32%，振幅8.57%。机构评级方面，在所有8家参与评级的机构中，38%的券商给予买入建议，50%的券商给予持有建议，12%的券商给予卖出建议。内克塔治疗股票所在的生物技术行业中，整体跌幅为1.63%。内克塔治疗公司简介：Nektar Therapeutics 是一家制药公司，专注于发现和开发选择性调节免疫系统以治疗自身免疫性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220005018984cdb9f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220005018984cdb9f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","NKTR"],"gpt_icon":0},{"id":"2492153700","title":"内克塔治疗盘中异动 股价大跌5.33%报0.966美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492153700","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492153700?lang=zh_cn&edition=full","pubTime":"2024-12-19 03:55","pubTimestamp":1734551706,"startTime":"0","endTime":"0","summary":"北京时间2024年12月19日03时55分，内克塔治疗股票出现异动，股价急速下挫5.33%。截至发稿，该股报0.966美元/股，成交量79.4456万股，换手率0.43%，振幅6.85%。机构评级方面，在所有8家参与评级的机构中，38%的券商给予买入建议，50%的券商给予持有建议，12%的券商给予卖出建议。内克塔治疗股票所在的生物技术行业中，整体跌幅为1.91%。内克塔治疗公司简介：Nektar Therapeutics 是一家制药公司，专注于发现和开发选择性调节免疫系统以治疗自身免疫性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219035507984cb778&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219035507984cb778&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","NKTR"],"gpt_icon":0},{"id":"2489914160","title":"内克塔治疗盘中异动 股价大跌5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2489914160","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489914160?lang=zh_cn&edition=full","pubTime":"2024-12-05 04:04","pubTimestamp":1733342669,"startTime":"0","endTime":"0","summary":"北京时间2024年12月05日04时04分，内克塔治疗股票出现异动，股价急速下跌5.14%。截至发稿，该股报1.02美元/股，成交量495.134万股，换手率2.68%，振幅5.61%。机构评级方面，在所有7家参与评级的机构中，29%的券商给予买入建议，57%的券商给予持有建议，14%的券商给予卖出建议。内克塔治疗股票所在的生物技术行业中，整体涨幅为0.43%。内克塔治疗公司简介：Nektar Therapeutics 是一家制药公司，专注于发现和开发选择性调节免疫系统以治疗自身免疫性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241205040429971bae3c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241205040429971bae3c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","NKTR"],"gpt_icon":0},{"id":"2488220670","title":"内克塔治疗盘中异动 股价大涨5.23%报1.20美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2488220670","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488220670?lang=zh_cn&edition=full","pubTime":"2024-12-02 23:00","pubTimestamp":1733151617,"startTime":"0","endTime":"0","summary":"北京时间2024年12月02日23时00分，内克塔治疗股票出现波动，股价快速拉升5.23%。截至发稿，该股报1.20美元/股，成交量14.2953万股，换手率0.08%，振幅3.95%。机构评级方面，在所有7家参与评级的机构中，29%的券商给予买入建议，57%的券商给予持有建议，14%的券商给予卖出建议。内克塔治疗股票所在的生物技术行业中，整体跌幅为0.02%。内克塔治疗公司简介：Nektar Therapeutics 是一家制药公司，专注于发现和开发选择性调节免疫系统以治疗自身免疫性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120223001798e4ecc3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120223001798e4ecc3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","NKTR"],"gpt_icon":0},{"id":"2486871590","title":"内克塔治疗盘中异动 早盘急速上涨5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2486871590","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486871590?lang=zh_cn&edition=full","pubTime":"2024-11-28 00:08","pubTimestamp":1732723719,"startTime":"0","endTime":"0","summary":"北京时间2024年11月28日00时08分，内克塔治疗股票出现波动，股价急速拉升5.14%。截至发稿，该股报1.13美元/股，成交量39.9937万股，换手率0.22%，振幅3.74%。机构评级方面，在所有7家参与评级的机构中，29%的券商给予买入建议，57%的券商给予持有建议，14%的券商给予卖出建议。内克塔治疗股票所在的生物技术行业中，整体涨幅为0.43%。内克塔治疗公司简介：Nektar Therapeutics 是一家制药公司，专注于发现和开发选择性调节免疫系统以治疗自身免疫性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112800083998e44f95&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112800083998e44f95&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NKTR","BK4007"],"gpt_icon":0},{"id":"2486368890","title":"内克塔治疗盘中异动 早盘快速上涨5.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2486368890","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486368890?lang=zh_cn&edition=full","pubTime":"2024-11-25 23:21","pubTimestamp":1732548079,"startTime":"0","endTime":"0","summary":"北京时间2024年11月25日23时21分，内克塔治疗股票出现异动，股价急速上涨5.24%。截至发稿，该股报1.11美元/股，成交量46.5422万股，换手率0.25%，振幅2.86%。机构评级方面，在所有7家参与评级的机构中，29%的券商给予买入建议，57%的券商给予持有建议，14%的券商给予卖出建议。内克塔治疗股票所在的生物技术行业中，整体涨幅为2.03%。内克塔治疗公司简介：Nektar Therapeutics 是一家制药公司，专注于发现和开发选择性调节免疫系统以治疗自身免疫性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112523211998e446f8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112523211998e446f8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","NKTR"],"gpt_icon":0},{"id":"2485261451","title":"内克塔治疗盘中异动 股价大涨5.45%报1.07美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2485261451","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485261451?lang=zh_cn&edition=full","pubTime":"2024-11-22 22:48","pubTimestamp":1732286937,"startTime":"0","endTime":"0","summary":"北京时间2024年11月22日22时48分，内克塔治疗股票出现异动，股价急速拉升5.45%。截至发稿，该股报1.07美元/股，成交量30.3846万股，换手率0.16%，振幅4.46%。机构评级方面，在所有7家参与评级的机构中，29%的券商给予买入建议，57%的券商给予持有建议，14%的券商给予卖出建议。内克塔治疗股票所在的生物技术行业中，整体涨幅为0.40%。内克塔治疗公司简介：Nektar Therapeutics 是一家制药公司，专注于发现和开发选择性调节免疫系统以治疗自身免疫性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122224857a24e28c5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122224857a24e28c5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NKTR","BK4007"],"gpt_icon":0},{"id":"2484104175","title":"内克塔治疗2024财年第三财季实现净利润-37.06百万美元，同比增加19.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484104175","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484104175?lang=zh_cn&edition=full","pubTime":"2024-11-17 00:03","pubTimestamp":1731772995,"startTime":"0","endTime":"0","summary":"11月17日，内克塔治疗公布财报，公告显示公司2024财年第三财季净利润为-37.06百万美元，同比增加19.15%；其中营业收入为24.12百万美元，同比减少0.08%，每股基本收益为-0.18美元。从资产负债表来看，内克塔治疗总负债2.59亿美元，其中短期债务21.50百万美元，资产负债比为1.19，流动比率为0.05。机构评级：截至2024年11月17日，当前有4家机构对内克塔治疗目标价做出预测，其中目标均价为3.58美元，其中最低目标价为1.30美元，最高目标价为7.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241117000423abc790ba&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241117000423abc790ba&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NKTR"],"gpt_icon":0},{"id":"2483964800","title":"内克塔治疗盘中异动 急速下挫5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483964800","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483964800?lang=zh_cn&edition=full","pubTime":"2024-11-14 23:20","pubTimestamp":1731597601,"startTime":"0","endTime":"0","summary":"北京时间2024年11月14日23时20分，内克塔治疗股票出现波动，股价急速下挫5.08%。截至发稿，该股报1.22美元/股，成交量27.9651万股，换手率0.15%，振幅6.25%。机构评级方面，在所有7家参与评级的机构中，29%的券商给予买入建议，57%的券商给予持有建议，14%的券商给予卖出建议。内克塔治疗股票所在的生物技术行业中，整体跌幅为0.88%。内克塔治疗公司简介：Nektar Therapeutics 是一家制药公司，专注于发现和开发选择性调节免疫系统以治疗自身免疫性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114232001abc17594&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114232001abc17594&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","NKTR"],"gpt_icon":0},{"id":"2483052688","title":"内克塔治疗盘中异动 临近收盘股价大跌5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483052688","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483052688?lang=zh_cn&edition=full","pubTime":"2024-11-13 04:53","pubTimestamp":1731444787,"startTime":"0","endTime":"0","summary":"北京时间2024年11月13日04时53分，内克塔治疗股票出现异动，股价大幅下跌5.11%。截至发稿，该股报1.30美元/股，成交量75.7911万股，换手率0.41%，振幅5.47%。机构评级方面，在所有7家参与评级的机构中，29%的券商给予买入建议，57%的券商给予持有建议，14%的券商给予卖出建议。内克塔治疗股票所在的生物技术行业中，整体跌幅为1.02%。内克塔治疗公司简介：Nektar Therapeutics 是一家制药公司，专注于发现和开发选择性调节免疫系统以治疗自身免疫性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113045307a231692d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113045307a231692d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NKTR","BK4007"],"gpt_icon":0},{"id":"2481192740","title":"Nektar Therapeutics 公布截至 9 月 30 日的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2481192740","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481192740?lang=zh_cn&edition=full","pubTime":"2024-11-08 12:39","pubTimestamp":1731040750,"startTime":"0","endTime":"0","summary":"Nektar Therapeutics 公布截至 9 月 30 日的季度业绩 - 收益摘要Nektar Therapeutics NKTR.OQ报告，截至9月30日的季度调整后每股亏损18美分，高于去年同期的每股-24美分。七位分析师对该季度的平均预期是每股亏损 21 美分。Nektar Therapeutics 公布的本季度每股收益为亏损 18 美分。该公司当季亏损 3706 万美元。Nektar Therapeutics 的股价本季度上涨了 6.9%，今年迄今为止上涨了 146.0%。华尔街对 Nektar Therapeutics 12 个月目标价的中位数为 4.00 本摘要由 LSEG 11 月 8 日上午 04:38  的调制解调器器生成。如有任何其他问题或反馈，请联系 RefinitivNewsSupport@thomsonreuters.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241108:nL4T3MF0H3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NKTR","BK4007"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.nektar.com","stockEarnings":[{"period":"1week","weight":-0.0636},{"period":"1month","weight":0.0098},{"period":"3month","weight":-0.2426},{"period":"6month","weight":-0.2746},{"period":"1year","weight":0.9074},{"period":"ytd","weight":0.1075}],"compareEarnings":[{"period":"1week","weight":-0.0194},{"period":"1month","weight":-0.0444},{"period":"3month","weight":0.0016},{"period":"6month","weight":0.0366},{"period":"1year","weight":0.2186},{"period":"ytd","weight":-0.0095}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Nektar Therapeutics于1990年在加州成立，并于1998年重新在特拉华州注册。该公司是一家临床阶段、研究型药物发现生物制药公司，专注于发现和开发免疫治疗领域的创新药物。在这个不断增长的领域内，该公司致力于创造新的免疫调节剂，选择性地诱导、放大、减弱或阻止免疫反应，以达到预期的治疗效果。","yearOnYearQuotes":[{"month":1,"riseRate":0.580645,"avgChangeRate":0.049899},{"month":2,"riseRate":0.5,"avgChangeRate":0.00268},{"month":3,"riseRate":0.4,"avgChangeRate":0.004229},{"month":4,"riseRate":0.433333,"avgChangeRate":0.006304},{"month":5,"riseRate":0.366667,"avgChangeRate":0.006185},{"month":6,"riseRate":0.387097,"avgChangeRate":-0.018715},{"month":7,"riseRate":0.451613,"avgChangeRate":-0.014995},{"month":8,"riseRate":0.451613,"avgChangeRate":0.034164},{"month":9,"riseRate":0.483871,"avgChangeRate":0.014638},{"month":10,"riseRate":0.354839,"avgChangeRate":-0.028591},{"month":11,"riseRate":0.677419,"avgChangeRate":0.089799},{"month":12,"riseRate":0.612903,"avgChangeRate":0.027386}],"exchange":"NASDAQ","name":"内克塔治疗","nameEN":"Nektar Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.30.0","shortVersion":"4.30.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"内克塔治疗(NKTR)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供内克塔治疗(NKTR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"内克塔治疗,NKTR,内克塔治疗股票,内克塔治疗股票老虎,内克塔治疗股票老虎国际,内克塔治疗行情,内克塔治疗股票行情,内克塔治疗股价,内克塔治疗股市,内克塔治疗股票价格,内克塔治疗股票交易,内克塔治疗股票购买,内克塔治疗股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"内克塔治疗(NKTR)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供内克塔治疗(NKTR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}